-
COMPARATIVE CARDIOVASCULAR AND KIDNEY EFFECTIVENESS OF GLP-1 RECEPTOR AGONISTS VERSUS OTHER GLUCOSE-LOWERING AGENTS IN PATIENTS WITH TYPE 2 DIABETES: A REAL-WORLD STUDY IN CHINA
Mar 18, 2026, 21:38 PM -
INTEGRATING RCT AND RWD FOR LONG-TERM NEONATAL OUTCOME EVALUATION: LESSONS FROM THE PRIME STUDY
Mar 18, 2026, 21:38 PM -
IMPACT OF GOLD-GUIDED PHARMACIST-LED PHARMACEUTICAL CARE ON CLINICAL OUTCOMES AND QUALITY OF LIFE IN COPD: A PROSPECTIVE RANDOMIZED TRIAL
Mar 18, 2026, 21:38 PM -
GIVE ME THE NUMBERS: FINE-GRAINED, STRUCTURED DATA EXTRACTION BEYOND NARRATIVE LLM OUTPUTS
Mar 18, 2026, 21:38 PM -
VARIABILITY IN DRUG-DRUG INTERACTION DATABASES AND ITS IMPLICATIONS FOR CLINICAL DECISION SUPPORT SYSTEMS: A CROSS-SECTIONAL STUDY FROM A TERTIARY CARE HOSPITAL IN INDIA
Mar 18, 2026, 21:38 PM -
EVOLUTION OF AI VALUE IN CHINESE CLINICAL PRACTICE: A 2025 SURVEY AND CASE SERIES ON PHYSICIAN-PRIORITIZED APPLICATIONS
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF SCREENING AND INTERVENTION STRATEGIES FOR PERINATAL DEPRESSION USING MULTI-STATE MARKOV MODEL IN RURAL CHINA
Mar 18, 2026, 21:38 PM -
AGENTIC PATIENT-REPORTED OUTCOMES (PROS): A CONCEPT-ANCHORED, PATIENT-CENTRIC, HUMAN-IN-THE-LOOP FRAMEWORK FOR AI-AUGMENTED INSTRUMENT DEVELOPMENT
Mar 18, 2026, 21:38 PM -
COST OF HEALTHCARE IN PATIENTS NEWLY DIAGNOSED WITH NON-CYSTIC FIBROSIS BRONCHIECTASIS
Mar 18, 2026, 21:38 PM -
EXPLORING THE ASSOCIATION BETWEEN CAREGIVER QOL AND THE CARE PROVIDED TO ADULTS WITH SEVERE VISUAL IMPAIRMENT CAUSED BY RARE DISEASE
Mar 18, 2026, 21:38 PM -
EXAMINING PLAN-LEVEL BID DEVIATIONS IN MEDICARE PART D: EVIDENCE FROM 2016-2025
Mar 18, 2026, 21:38 PM -
ENDOCRINE RESISTANCE AND REAL-WORLD TREATMENT PATTERNS AFTER FIRST-LINE (1L) ET+CDK4/6I IN HR+/HER2-METASTATIC BREAST CANCER (MBC)
Mar 18, 2026, 21:38 PM -
ESTIMATING THE COST OF ORPHAN DRUG TREATMENT FROM THE PERSPECTIVE OF MEXICO'S PUBLIC SECTOR
Mar 18, 2026, 21:38 PM -
MULTIDISCIPLINARY TEAM MEETING IN DIGESTIVE CANCERS: “A 6-YEAR EXPERIENCE IN AN ALGERIAN REFERENCE CANCER CENTER”
Mar 18, 2026, 21:38 PM -
CHARACTERIZING THE U.S. MEDICAID POPULATION BY FEDERAL POVERTY LEVEL: DEMOGRAPHICS, REGIONAL PATTERNS, AND AFFORDABLE CARE ACT (ACA) EXPANSION STATUS TO ASSESS POLICY SHIFTS UNDER THE ONE BIG BEAUTIFUL BILL ACT (H.R.1)
Mar 18, 2026, 21:38 PM -
MARKET SHARE AND ECONOMIC TRENDS OF JANUS KINASE INHIBITORS IN U.S. MEDICAID, 2011- 2023
Mar 18, 2026, 21:38 PM -
GENERAL-PURPOSE VS HEOR-SPECIFIC GENERATIVE AI IN RARE DISEASE MODELING: A DUCHENNE MUSCULAR DYSTROPHY CASE STUDY
Mar 18, 2026, 21:38 PM -
EFFECT MODIFICATION BY MULTIMORBIDITY BURDEN ON THE EFFECTIVENESS AND SAFETY OF SGLT2 INHIBITORS IN OLDER ADULTS WITH T2D: A TARGET TRIAL EMULATION STUDY
Mar 18, 2026, 21:38 PM -
ALTERNATIVE ANALYTICAL APPROACHES TO INVESTIGATING THE ASSOCIATION BETWEEN TIMELINESS OF LUNG CANCER TREATMENT AND SURVIVAL
Mar 18, 2026, 21:38 PM -
OPTIMIZATION OF PROSTATE CANCER BIOPSY DECISION-MAKING IN KOREAN PATIENTS USING MACHINE LEARNING
Mar 18, 2026, 21:38 PM
